{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T20:38:01Z","timestamp":1719952681677},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81373415"],"award-info":[{"award-number":["81373415"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ejphar.2018.01.022","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T04:13:50Z","timestamp":1517372030000},"page":"51-58","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dual inhibition of HY023016 based on binding properties of platelet membrane receptor subunit glycoprotein Ib\u03b1 and thrombin exosites"],"prefix":"10.1016","volume":"822","author":[{"given":"Qiu-fang","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-liang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-zhan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-gen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-qing","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejphar.2018.01.022_bib1","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1111\/j.1538-7836.2009.03563.x","article-title":"Molecular basis of thrombomodulin activation of slow thrombin","volume":"7","author":"Adams","year":"2009","journal-title":"J. Thromb. Haemost."},{"issue":"21","key":"10.1016\/j.ejphar.2018.01.022_bib2","doi-asserted-by":"crossref","first-page":"8326","DOI":"10.1021\/bi00447a010","article-title":"Cross-linking of a monomeric 39\/34-kDa dispase fragment of von Willebrand factor (Leu-480\/Val-481-Gly-718) to the N-terminal region of the alpha-chain of membrane glycoprotein Ib on intact platelets with bis(sulfosuccinimidyl) suberate","volume":"28","author":"Andrews","year":"1989","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2018.01.022_bib3","first-page":"13","article-title":"Preparation of washed platelet suspensions from human and rodent blood","volume":"272","author":"Cazenave","year":"2004","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejphar.2018.01.022_bib4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejphar.2016.04.023","article-title":"Evaluating antithrombotic activity of HY023016 on rat hypercoagulable model","volume":"781","author":"Chen","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2018.01.022_bib5","first-page":"756","article-title":"Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality","volume":"98","author":"Cohen","year":"2007","journal-title":"Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.ejphar.2018.01.022_bib6","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/j.1538-7836.2005.01377.x","article-title":"Protease-activated receptors in hemostasis, thrombosis and vascular biology","volume":"3","author":"Coughlin","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"41","key":"10.1016\/j.ejphar.2018.01.022_bib7","doi-asserted-by":"crossref","first-page":"12421","DOI":"10.1021\/bi970636b","article-title":"The cytoplasmic domain of glycoprotein (GP) Ibalpha constrains the lateral diffusion of the GP Ib-IX complex and modulates von Willebrand factor binding","volume":"36","author":"Dong","year":"1997","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/j.ejphar.2018.01.022_bib8","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1161\/ATVBAHA.110.203604","article-title":"Dabigatran: an oral novel potent reversible nonpeptide inhibitor of thrombin","volume":"30","author":"Eisert","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9","key":"10.1016\/j.ejphar.2018.01.022_bib9","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1111\/j.1538-7836.2006.02152.x","article-title":"Incidence and risk of venous thromboembolism in patients with verified arterial thrombosis: a population study based on 23,796 consecutive autopsies","volume":"4","author":"Eliasson","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.ejphar.2018.01.022_bib10","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.amjcard.2007.06.034","article-title":"Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study)","volume":"100","author":"Ezekowitz","year":"2007","journal-title":"Am. J. Cardiol."},{"issue":"7","key":"10.1016\/j.ejphar.2018.01.022_bib11","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ejim.2007.10.019","article-title":"Venous and arterial thrombosis: different sides of the same coin?","volume":"19","author":"Franchini","year":"2008","journal-title":"Eur. J. Intern. Med."},{"issue":"41","key":"10.1016\/j.ejphar.2018.01.022_bib12","doi-asserted-by":"crossref","first-page":"25493","DOI":"10.1074\/jbc.272.41.25493","article-title":"Evidence for allosteric linkage between exosites 1 and 2 of thrombin","volume":"272","author":"Fredenburgh","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.ejphar.2018.01.022_bib13","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/STROKEAHA.111.000457","article-title":"Characterization of arterial thrombus composition by magnetic resonance imaging in a swine stroke model","volume":"44","author":"Fujimoto","year":"2013","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.ejphar.2018.01.022_bib14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0021-9258(17)42483-5","article-title":"von Willebrand factor. A reduced and alkylated 52\/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib","volume":"261","author":"Fujimura","year":"1986","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ejphar.2018.01.022_bib15","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0021-9258(17)42258-7","article-title":"Identification of basic amino acid residues in thrombin essential for heparin-catalyzed inactivation by antithrombin III","volume":"269","author":"Gan","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.ejphar.2018.01.022_bib16","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1073\/pnas.0710894105","article-title":"Structural identification of the pathway of long-range communication in an allosteric enzyme","volume":"105","author":"Gandhi","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.ejphar.2018.01.022_bib17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s13181-011-0178-y","article-title":"Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant","volume":"7","author":"Ganetsky","year":"2011","journal-title":"J. Med. Toxicol."},{"issue":"52","key":"10.1016\/j.ejphar.2018.01.022_bib18","doi-asserted-by":"crossref","first-page":"21216","DOI":"10.1073\/pnas.1218414109","article-title":"Allosteric networks in thrombin distinguish procoagulant vs. anticoagulant activities","volume":"109","author":"Gasper","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.ejphar.2018.01.022_bib19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.beha.2012.06.007","article-title":"Venous thromboembolism: epidemiology and magnitude of the problem","volume":"25","author":"Goldhaber","year":"2012","journal-title":"Best. Pract. Res. Clin. Haematol."},{"issue":"2","key":"10.1016\/j.ejphar.2018.01.022_bib20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1055\/s-0038-1653684","article-title":"Ristocetin--a new tool in the investigation of platelet aggregation","volume":"26","author":"Howard","year":"1971","journal-title":"Thromb. Diath. Haemorrh."},{"issue":"8","key":"10.1016\/j.ejphar.2018.01.022_bib21","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1111\/j.1538-7836.2005.01363.x","article-title":"Molecular recognition mechanisms of thrombin","volume":"3","author":"Huntington","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.ejphar.2018.01.022_bib22","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1160\/TH13-10-0811","article-title":"Natural inhibitors of thrombin","volume":"111","author":"Huntington","year":"2014","journal-title":"Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.ejphar.2018.01.022_bib23","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1182\/blood-2006-12-027698","article-title":"The growing complexity of platelet aggregation","volume":"109","author":"Jackson","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ejphar.2018.01.022_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0268-960X(02)00008-5","article-title":"The post-thrombotic syndrome: current knowledge, controversies, and directions for future research","volume":"16","author":"Kahn","year":"2002","journal-title":"Blood Rev."},{"issue":"Suppl.1","key":"10.1016\/j.ejphar.2018.01.022_bib25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/jth.12217","article-title":"The transition of prothrombin to thrombin","volume":"11","author":"Krishnaswamy","year":"2013","journal-title":"J. Thromb. Haemost."},{"issue":"32","key":"10.1016\/j.ejphar.2018.01.022_bib26","doi-asserted-by":"crossref","first-page":"14087","DOI":"10.1073\/pnas.1005255107","article-title":"NMR resonance assignments of thrombin reveal the conformational and dynamic effects of ligation","volume":"107","author":"Lechtenberg","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.ejphar.2018.01.022_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0049-3848(01)00343-7","article-title":"Specific inhibiting characteristics of tetramethylpyrazine, one of the active ingredients of the Chinese herbal medicine 'Chuanxiong,' on platelet thrombus formation under high shear rates","volume":"104","author":"Li","year":"2001","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.ejphar.2018.01.022_bib28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.thromres.2013.03.004","article-title":"Antithrombotic activity of HY023016, a novel Dabigatran prodrug evaluated in animal thrombosis models","volume":"131","author":"Li","year":"2013","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.ejphar.2018.01.022_bib29","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1046\/j.1538-7836.2003.00027.x","article-title":"Fibrinogen gamma' chain binds thrombin exosite II","volume":"1","author":"Lovely","year":"2003","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.ejphar.2018.01.022_bib30","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1016\/j.thromres.2010.03.022","article-title":"The antithrombotic effect of a novel hirudin derivative after reconstruction of carotid artery in rabbits","volume":"126","author":"Lu","year":"2010","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ejphar.2018.01.022_bib31","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/202498a0","article-title":"An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier","volume":"202","author":"Macfarlane","year":"1964","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ejphar.2018.01.022_bib32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.beha.2013.07.001","article-title":"Bleeding and antidotes in new oral anticoagulants","volume":"26","author":"Majeed","year":"2013","journal-title":"Best Pract. Res. Clin. Haematol."},{"issue":"1","key":"10.1016\/j.ejphar.2018.01.022_bib33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jbbm.2004.04.016","article-title":"Sample displacement chromatography of Atlantic Salmon (Salmo salar) thrombin","volume":"60","author":"Manseth","year":"2004","journal-title":"J. Biochem. Biophys. Methods"},{"issue":"22","key":"10.1016\/j.ejphar.2018.01.022_bib34","doi-asserted-by":"crossref","first-page":"13406","DOI":"10.1074\/jbc.270.22.13406","article-title":"Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor","volume":"270","author":"Matsushita","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ejphar.2018.01.022_bib35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0049-3848(01)00273-0","article-title":"Fibrinogen naples I (B beta A68T) nonsubstrate thrombin-binding capacities","volume":"103","author":"Meh","year":"2001","journal-title":"Thromb. Res."},{"issue":"11","key":"10.1016\/j.ejphar.2018.01.022_bib36","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1074\/jbc.275.11.7539","article-title":"Interaction of von Willebrand factor domain A1 with platelet glycoprotein Ibalpha-(1-289). Slow intrinsic binding kinetics mediate rapid platelet adhesion","volume":"275","author":"Miura","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ejphar.2018.01.022_bib37","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1172\/JCI9896","article-title":"Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen","volume":"106","author":"Ni","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.ejphar.2018.01.022_bib38","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1073\/pnas.92.7.2455","article-title":"Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras","volume":"92","author":"Nichols","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.ejphar.2018.01.022_bib39","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1055\/s-0037-1617033","article-title":"Factor Xa inhibitors--new anticoagulants for secondary haemostasis","volume":"29","author":"Perzborn","year":"2009","journal-title":"Hamostaseologie"},{"issue":"2\u20133","key":"10.1016\/j.ejphar.2018.01.022_bib40","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.bpc.2006.08.005","article-title":"Crystal structure of thrombin in complex with fibrinogen gamma' peptide","volume":"125","author":"Pineda","year":"2007","journal-title":"Biophys. Chem."},{"issue":"24","key":"10.1016\/j.ejphar.2018.01.022_bib41","doi-asserted-by":"crossref","first-page":"21584","DOI":"10.1074\/jbc.M300545200","article-title":"Evidence that both exosites on thrombin participate in its high affinity interaction with fibrin","volume":"278","author":"Pospisil","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ejphar.2018.01.022_bib42","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1182\/blood.V74.3.1031.1031","article-title":"Role of botrocetin in platelet agglutination: formation of an activated complex of botrocetin and von Willebrand factor","volume":"74","author":"Read","year":"1989","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ejphar.2018.01.022_bib43","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ab.2003.07.023","article-title":"Glutathione S-transferase pull-down assays using dehydrated immobilized glutathione resin","volume":"322","author":"Ren","year":"2003","journal-title":"Anal. Biochem."},{"issue":"11","key":"10.1016\/j.ejphar.2018.01.022_bib44","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nm1102-1227","article-title":"Platelets in atherothrombosis","volume":"8","author":"Ruggeri","year":"2002","journal-title":"Nat. Med"},{"issue":"5","key":"10.1016\/j.ejphar.2018.01.022_bib45","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1160\/TH10-09-0578","article-title":"Unravelling the mechanism and significance of thrombin binding to platelet glycoprotein Ib","volume":"104","author":"Ruggeri","year":"2010","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ejphar.2018.01.022_bib46","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","article-title":"Biochemistry and genetics of von Willebrand factor","volume":"67","author":"Sadler","year":"1998","journal-title":"Annu. Rev. Biochem."},{"issue":"7","key":"10.1016\/j.ejphar.2018.01.022_bib47","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1021\/bi026549n","article-title":"Cytoplasmic truncation of glycoprotein Ib alpha weakens its interaction with von Willebrand factor and impairs cell adhesion","volume":"42","author":"Schade","year":"2003","journal-title":"Biochemistry"},{"issue":"12","key":"10.1016\/j.ejphar.2018.01.022_bib48","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1073\/pnas.91.12.5518","article-title":"Molecular mapping of the heparin-binding exosite of thrombin","volume":"91","author":"Sheehan","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6 Suppl","key":"10.1016\/j.ejphar.2018.01.022_bib49","doi-asserted-by":"crossref","first-page":"234S","DOI":"10.1378\/chest.08-0673","article-title":"New antithrombotic drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Weitz","year":"2008","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ejphar.2018.01.022_bib50","first-page":"155","article-title":"In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate","volume":"98","author":"Wienen","year":"2007","journal-title":"Thromb. Haemost."},{"issue":"21","key":"10.1016\/j.ejphar.2018.01.022_bib51","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.1021\/bi00524a036","article-title":"Carboxy-terminal amino acid sequence of a human fibrinogen gamma-chain variant (gamma')","volume":"20","author":"Wolfenstein-Todel","year":"1981","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2018.01.022_bib52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejmech.2012.09.016","article-title":"Synthesis and antithrombotic evaluation of novel dabigatran prodrugs containing a cleavable moiety with anti-platelet activity","volume":"57","author":"Yang","year":"2012","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejphar.2018.01.022_bib53","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ccd.21999","article-title":"Anticoagulation with the direct thrombin inhibitor argatroban in patients presenting with acute coronary syndromes","volume":"74","author":"Yeh","year":"2009","journal-title":"Catheter. Cardiovasc. Interv."},{"issue":"21","key":"10.1016\/j.ejphar.2018.01.022_bib54","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.1017042108","article-title":"Binding of alpha-thrombin to surface-anchored platelet glycoprotein Ib(alpha) sulfotyrosines through a two-site mechanism involving exosite I","volume":"108","author":"Zarpellon","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2018.01.022_bib55","first-page":"531","article-title":"Assays of thrombin, hirudin and lumbrokinase with light scattering in the solution of fibrinogen","volume":"4","author":"Zhou","year":"1997","journal-title":"Acta Biophys. Sin."},{"issue":"8","key":"10.1016\/j.ejphar.2018.01.022_bib56","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.fitote.2011.08.009","article-title":"In vitro metabolism in Sprague-Dawley rat liver microsomes of forsythoside A in different compositions of Shuang-Huang-Lian","volume":"82","author":"Zhou","year":"2011","journal-title":"Fitoterapia"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918300281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918300281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T20:50:20Z","timestamp":1719780620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918300281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":56,"alternative-id":["S0014299918300281"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.01.022","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual inhibition of HY023016 based on binding properties of platelet membrane receptor subunit glycoprotein Ib\u03b1 and thrombin exosites","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}